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ABSTRACT 
The anomalous origin of the left coronary artery from the pulmonary artery 
(ALCAPA) is a rare congenital heart defect occuning approximately one out of every 
300,000 live births. ALCAPA is a coronary artery anomaly in which the left coronary 
artery originates anomalously from the pulmonary trunk rather than from its usual origin, 
the aorta. It is a serious heart defect with a presentation range from severe congestive 
heart fai lure and left ventricular dysfunction in infants to asymptomatic survival into 
adulthood. ALCAP A is one of the most common causes of myocardial ischemia and 
infarction in infants and children, and if untreated can cause death in up to 90% of cases 
due to hea.J.i failure. 
With technological advances in diagnosis and treatment, there are increasing 
numbers of ALCAP A patients surviving into adulthood. This trend is seen with CHD in 
general with over 85% oftreated children born with CHD surviving into adulthood today 
with an estimated increase in the next few decades . Although ALCAP A patients undergo 
"corrective" surgery, they are never truly cured, and patients must manage their condition 
as a mild, moderate, or potentially severe chronic disease. Through a review of cunent 
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literature about ALCAP A patients and adults with CHD in general, this thesis explores 
the postoperative physiological outcome, psychosocial effects, and health care options of 
treated pediatric ALCAP A patients that survived into adulthood. 
We have found that there are still significant unknowns about the future of adult 
ALCAP A survivors. First, earlier diagnosis and treatment of ALCAP A can lead to good 
outcomes, yet it is unknown whether it is feasible to find the defect before it manifests 
and treat it before any damage has occurred. Secondly, long-term studies of patients are 
currently insufficient to determine the health of these patients past a decade or two. 
Lastly, the current health care options for ALCAP A and adults with CHD in general do 
not currently meet the needs of this unique population, as they require highly specialized 
services in order to ensure their health. 
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INTRODUCTION 
Congenital heart defects (CHD) are the most common and lethal birth defects 
with about 35,000 babies born with CHD each year in the United States1'2 The 
anomalous origin of the left coronary artery from the pulmonary artery (ALCAP A) is a 
rare CHD that occurs approximately one out of every 300,000 live births3 ALCAP A is a 
coronary artery anomaly in which the left coronary artery (LCA) originates anomalously 
from the pulmonary trunk (P A) rather than from its usual origin, the aorta. It is a serious 
heart defect with a presentation that ranges from severe congestive heart failure and left 
ventricular dysfunction in infants to asymptomatic survival into adulthood4 ALCAP A is 
normally an isolated malformation, but can be associated with other CHD such as patent 
ductus arteriosus, ventricular septal defects, tetralogy ofF allot, or coarction of the aorta5 . 
The cause of this defect, like most CHD, is unknown and thought to be multifactorial : a 
consequence of many possible risk factors including family history of CHD, maternal 
diabetes, or maternal drug use2'6 Regardless of the cause, ALCAP A develops due to an 
abnormality in the differentiation of the truncus arteriosus during fetal cardiac 
development 7'8 The truncus arteriosus is the precursor of the great arteries and from 
which the coronary arteries bud8 It is believed that either a slight difference in the 
division of the great arteries or a displacement of the LCA bud on the truncus arteriosus 
can result in ALCAP A 8. 
This defect predominantly presents in infants and is one of the most common 
causes of myocardial ischemia and infarction in infants and children9 . If untreated, 
ALCAP A can cause death in up to 90% of cases due to heart failure 10' 11 . Although some 
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untreated adults with ALCAP A exist and are usually asymptomatic, they carry the risk of 
progressive cardiac dysfunction, arrhythmias, and sudden death12' 13 Because of the 
variation in presentation, there are different methods of treatment recommended based on 
the ALCAP A type14 and the unique anatomy of each patient. With early surgical 
treatment, most ALCAP A patients are expected to live a normallife15 . 
Anatomy 
Normally, both coronary arteries originate from the aorta, but in ALCAP A, only 
the right coronary artery (RCA) originates from the aorta while the left coronary artery 
originates from the pulmonary artery. Although the origin is different, the LCA still 
supplies blood to the left ventricle (LV) . If insufficient oxygenated blood is delivered to 
the left ventricle, the cardiac muscle of the ventricular walls develop ischemia and 
ultimately result in depressed LV function (Figure 1 ). 
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Figure 1. Anatomic Representation of ALCAP A. Diagram showing the primary 
difference between a normal heart (on the I eft) and an ALCAP A heart (on the right) . 
Normally, the LCA branches from the aorta and feeds the left heart with oxygenated 
blood. In ALCAP A, the LCA branches from the pulmonary artery leading to poor 
nutrition and tissue ischemia of the left ventricle and with time, tissue death. Notice that 
the RCA in the ALCAP A heart is much larger than normal. (Downloaded from 
"MedlinePlus at http ://www.nlm. nih. gov/medlineplus/ency/imagepages/19889. htm"). 
During fetal development, the patent ductus arteriosus connects the systemic and 
pulmonary circulations allowing blood to bypass the developing lungs. At this stage, the 
blood pressures of the pulmonary and systemic circulations are about the same in the 
fetus and allow adequate perfusion of the anomalous LCA via the pulmonary artery16. At 
birth, with the expansion of the lungs, the resistance in the pulmonary bed falls and the 
patent ductus arteriosus closes resulting in falling pulmonary artery pressures and 
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separation of the two circulations17 With the closing of the ductus arteriosus, the 
pulmonary artery and the LCA pressures gradually fall below systemic pressures and 
RCA pressures16 Over time a sufficient decrease in pulmonary resistance and pulmonary 
arterial pressure can result in a diastolic pressure of the LCA too low to adequately 
perfuse the left ventricular myocardium 18. Yet, the heart can adapt to a certain extent 
Intercoronary collateral vessels connecting the left and right coronary arteries can 
develop in response to myocardial hypoxia and shunt blood into the LCA19 . These 
collateral vessels allow blood to flow from the relatively high resistance and pressure 
aorta via the RCA through collateral vessels and into the low resistance and pressure 
LCA16 . As the collateral vessels develop, the LCA wall becomes thin and resembles a 
venous channef0 while the RCA becomes tortuous and dilated in order to accommodate 
the increased blood volume21 . The retrograde flow from the RCA to the LCA is known as 
the coronary steal phenomenon22 and can provide the LCA with oxygen rich blood. With 
increased amount of intracoronary collateral vessels, there is an increase in coronary steal 
between the arteries, which can be beneficial in providing the left ventricle with the 
perfusion it needs for proper function . Yet, because the anomalous LCA is attached to the 
low pressure pulmonary artery (P A), blood also flows from the LCA into the P A, creating 
a left-to-right shunt16 If significantly large enough, this shunt may result in the 
myocardial steal phenomenon, which can hinder left ventricular perfusion and cause 
ischemia of the LV myocardial tissue7 
There is commonly mitral valve regurgitation (MR) at the time of ALCAP A 
diagnosis. In a pediatric study, 75% of ALCAP A patients had some degree of MR 
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preoperativel/3 . The cause of the mitral valve regurgitation is thought to be due to 
papillary muscle ischemia, dilation of the valve annulus, or both24 . The anterolateral 
papillary muscle can be atrophied and scarred, sometimes calcified, impairing the 
effectiveness of the valve5 Rarely, mitral regurgitation is due to mitral valve prolapse or 
some other associated lesion25 . 
Specific Aims 
With technological advances in diagnosis and treatment, there are increasing 
numbers of ALCAP A patients surviving into adulthood. Although undergoing 
"corrective" surgery, patients are never really cured, and must still manage their 
condition as a mild, moderate, or a potentially severe chronic disease26 These patients 
have a very different physiology and as they become adults will face problems for which 
a general pediatric cardiologist or adult cardiologist alone is not prepared27'28 This thesis 
will look into the long-term physiological outcomes, psychosocial effects, and health care 
options of those individuals with ALCAP A diagnosed and treated during childhood who 
are now adults. We will also explore the psychosocial aspect of growing up with 
ALCAP A and how this defect changes the lives of these patients socially, 
psychologically, and in their quality of life. We will then look into the medical options 
for these aging patients and the current success in meeting the medical, psychological, 
and social needs of ALCAP A patients and adults with congenital heart defects (ACHD) 
in general. The goal of this thesis is to examine the lives of these patients postoperatively 
and evaluate if current health system is able to meet their specific needs. It is important 
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for doctors and society to understand the difficulties, medically and otherwise, that these 
patients face throughout their lives in order to help them live as happy and productive 
members of society. 
PRESENTATION 
ALCAP A, also known as Bland-White-Garland Syndrome, was first clinically 
described by Bland and colleagues in a 1933 case report of an infant presenting with 
dyspnea, grunting, and pallor29 Before the development of surgical treatment, ALCAP A 
resulted in death within the first year of life in most cases30 . Survival into adulthood 
without treatment is possible, but occurs rarely and depends on the number of collateral 
vessels that develop between the RCA and LCA25 
ALCAP A is differentiated into two types: the infant type and the adult type22 The 
difference between the two types depends upon the degree of collateral circulation which 
dictates when the patient will present; those with sufficient collateral circulation are of 
the adult type, while those with poor collateral circulation are of the infantile type14 
(Figure 2) . Collateral vessel development between the RCA and LCA determines the 
extent of myocardial ischemia of the left ventricle and therefore the severity of 
presentation25 In the infant type, there is little to no collateral vessel development 
leaving the left ventricle with poor perfusion and myocardial ischemia that can ultimately 
result in left ventricular dysfunction, heart failure, and death if not treated promptly22 In 
the adult type, the numerous intercoronary collaterals result in a large coronary steal 
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sufficient enough to supply and nourish the left ventricle30 so that no or little myocardial 
ischemia develops and typically allows survival of the patient past infanthood18 
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Figure 2. Collateral circulation in ALCAPA. Diagram shows differences in circulation 
and presentation of ALCAP A types. (Pefia et al. , 2009) 
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Infant ALCAPA Type 
Infantile ALCAP A usually presents in the first year of life and is much more 
prevalent and lethal than the adult type31 . In the historic paper by Bland and colleagues, a 
case of a 3 month old patient with infantile ALCAP A is described29 . The child ' s 
condition worsened over the few weeks after hospitalization with more severe 
respiratory attacks from which the child ultimately died32 On inspection by autopsy, the 
left coronary artery originated from the pulmonary artery and the left ventricle was 
hypertrophic and dilated with microscopic signs of patchy fibrosis32 
In the infantile type, patients usually appear normal with a healthy appearance for 
the first month after birth3 . Patients present symptoms weeks or months after birth when 
the pressure in the pulmonary artery starts to decline and the patent ductus arteriosus 
closes10 . While open, the ductus arteriosus prevents the fall of pulmonary artery pressures 
and allows oxygenated blood to flow anterograde from the P A into the LCA33 . When the 
ductus arteriousus closes, the low pressure of the P A will decrease and reverse blood 
flow in the LCA, stealing blood from the myocardium and leading to progressive 
myocardial ischemia22 
Symptoms typically present in infants as sudden attacks usually occurring after 
feeding or crying that include pallor, sweating, dyspnea and angina-like episodes34 
Patients may also present with a failure to thrive. In these patients there is little coronary 
steal due to poor intercoronary collateral circulation and inadequate perfusion of the area 
normally nourished by the LCA35 . This causes myocardial ischemia and eventual 
infarction of left ventricular myocardium and papillary muscles18 The degree of LV 
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infarction differs between patients and can range from subendocardial, involving just a 
thin layer of muscle, to transmural, involving the full thickness of muscle, but is often 
patchy in distribution36 . The associated papillary muscle fibrosis results in mitral valve 
dysfunction with mitral valve regurgitation in a majority of patients23 The degree of MR. 
significantly increases the risk of morbidity and mortality in untreated infants37 In cases 
of infant with ALCAP A developed LV infarction and MR, heart failure is common and 
can be severe, persistent, and life threatening5 . 
Adult ALCAPA Type 
Adult ALCAP A patients typically survive their first year of life and may even 
survive to an elderly age31. These patients present clinically with no or relatively few 
symptoms such as exertional angina, palpitations, or a murmur18'31 . Patients may be 
asymptomatic for years or decades, even through multiple pregnancies25'38 Although 
there is oxygenated blood in the LCA from sufficient coronary steal from the RCA, a 
portion of the blood goes into the P A and "steals" from the myocardium to some extent39 
Over time, the myocardial steal from the LCA into the P A may increase due to elevated 
systemic blood pressures with age, increasing the left-to-right shunt and gradually cause 
ischemia of the left ventricle18 If a continuous murmur can be heard either at rest or after 
exercise, it is diagnostic of a significant left-to-right shunt of blood into the P A 40 
Depending on the balance between coronary steal and myocardial steal, these patients 
may range from good LV function and relatively mild ischemia5 to significant LV 
dysfunction and mitral valve regurgitation4 1. 
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Because of the altered coronary circulation in these patients, the left ventricle is 
abnormal with dysrhythmias and signs of chronic myocardial ischemia, putting these 
patients at risk for cardiac arrest40 In this population there is a high risk of sudden death 
if untreated5'41 with an 80-90% incidence of sudden death by age 3 513 . Yet, it has been 
found that as these patients get older, there is a decrease in the risk of life-threatening 
presentation and sudden death31. 
DIAGNOSIS 
Although treatment has advanced, it is very important to diagnose this 
malformation as early as possible before severe cardiac failure occurs29 It is 
recommended that ALCAP A be suspected in all young infants with ventricular 
dysfunction and symptoms of myocardial infarction42 including pallor and crying after 
exertion35. Advances in diagnostic techniques for ALCAP A have become less invasive 
and allow for an earlier and easier diagnosis of patients. 
Electrocardiogram (ECG) 
The electrocardiogram can be used to study the electrical depolarization and 
repolarization of the heart chambers by placing 12 electrodes on the patient that surround 
the heart43. There are three limb leads each placed on limbs of the patient (leads I, II, and 
III), three augmented leads placed on the frontal plane facing the heart (leads a VR, a VL, 
and a VF), and six precordial leads placed on the front of the thorax(V 1- V 6) 43 Each lead 
giVes a reading with respect to its position with positive and upward readings 
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representing electrical impulses traveling toward the electrode and negative and 
downward readings representing electrical impulses traveling away from the electrode43 . 
In ECGs, there are normally 5 distinguishable points: the P, Q, R, S, and T waves. The 
first point is the P wave representing the depolarization of the atria prior to atrial 
contraction. Next is the QRS complex, 3 points that represents ventricular depolarization 
prior to ventricular contraction. Following the QRS complex is the T wave representing 
the repolarization of the ventricles. Characteristic changes found on ECGs of patients can 
identify a presence of ischemia and/or infarction ofthe myocardial tissue43 . 
The electrocardiograms of infants with ALCAP A are similar to those of adult 
patients suffering from coronary artery disease (CAD)32 Like adults with CAD, in 
ALCAP A there is poor coronary perfusion of the hea11 that results in ischmia and 
infarction. In ALCAP A, there are abnormal Q waves indicating myocardial infarction 44 
and inverted T waves in leads I, a VL, and V 4- V 6 45 representative of left ventricular 
ischemia or hypertrophy, or both20 Although ECGs in these infants are usually abnormal, 
a normal ECG is not enough evidence to rule out ALCAP A 42 A progressive infarct 
pattern in infants indicates the need for surgical treatment 46 . 
Adult type ALCAP A ECGs typically show signs of lateral ischemia, myocardial 
infarction47, and moderate to mild hypertrophy14. 
X-ray 
X-ray films of the chest typically show cardiac enlargement especially of the left 
ventricle32 Due to altered perfusion in ALCAP A, the left ventricle typically has 
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decreased function and therefore decreased contractility48 The LV dilates to increase 
volume input in order to compensate for poor ventricular ejection so that even with a 
lower LV ejection fraction, cardiac output can be maintained 18. Although cardiomegaly is 
an indication of poor arterial perfusion of the myocardium49'50 it is not particularly useful 
in differentiating ALCAP A from other forms of CHD34 
Cardiac Catheterization and Angiography 
Cardiac catheterization with aortic root angiography remains a useful method of 
definitively diagnosing ALCAP A25'45 This test is performed by the insertion of a catheter 
into the femoral artery, advancing it up the descending aorta to the aortic arch and then to 
the aortic root just above the aortic valve. A contrast agent is then injected through the 
catheter while fluoroscopy images are acquired. Flow of the contrast through the 
coronary arteries can be visualized34' 51. This technique detects the origin, course, and 
flow through each coronary artery and the collateral vessels between them52 In 
ALCAP A, an aortography will show dye flowing from the aorta into a dilated but 
otherwise normal RCA and retrograde flow from the anomalous LCA into the P A 45 . 
A coronary angiography can also provide a definitive diagnosis for ALCAP A as it 
can also detect the left-to-right shunt into the PA25 This technique is similar to aortic 
angiography, with the exception that dye is originally released within a coronary artery 
instead of the aorta 53 . 
Angiography is invasive and carries a risk of complications22 especially in infants 
and children with acute congestive heart failure, and less invasive methods for diagnosis 
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should be used9 . Luckily, with the advances in diagnostic methods, aortic and coronary 
angiograms are no longer necessary for ALCAP A diagnosis in the current age24 
Echocardiography 
Unlike some CHD, ALCAP A cannot be detected in utero by ultrasound during 
routine screenings2 because the coronary arteries are too small to visualize and the 
malformation does not cause physiological effect until after birth. Post-natally, two-
dimensional echocardiography can identify the coronary artery origins as normal or 
anomalous from the pulmonary trunk8. Although the inability to image the normal aortic 
origin of the LCA does not necessarily mean the vessel is anomalous20 Echocardiograms 
can also detect a grossly enlarged RCA 24 and dilated L V54 
Current research indicates that echocardiography can be sufficient to provide an 
accurate diagnosi s of ALCAP A, especially in infants 55. The detection of retrograde flow 
in the LCA and an abnormal stream of blood into the pulmonary trunk by Pulsed Doppler 
in combination with color flow mapping is sufficient evidence for an ALCAP A 
diagnosis8'24'56 Color-flow Doppler echocardiograms can also be used to determine LV 
function and the presence of mitral regurgitation57 In adult type patients, pulsed and 
color-flow Doppler can show evidence of a dilated RCA, continuous blood flow from 
LCA to P A, and a visualization of collateral vessels24'25 . 
Dobutamine stress echocardiography (DSE) can reveal hibernating myocardium, 
ischemic yet potentially viable myocardium24 . DSE can also be used to distinguishing 
MR from mitral valve prolapse and direct the surgical treatment of the mitral valve5 
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Transthoracic echocardiograms in infants are currently the favored diagnostic 
technique given the ease ofuse and lack ofradiation4 However, a high clinical suspicion 
of ALCAP A even with a seemingly normal echocardiogram should prompt further 
investigation with alternative diagnostic modality such as cardiac catheterization or CT. 
Computerized Topography (CT) 
64-slice CT can be used as an alternative to angiograph/4 as it is fast and widely 
available18 Multidetector CT offers high spatial and temporal resolution and an accurate, 
detailed, and contrast-enhanced visualization ofthe coronary arteries4 Yet, there are 
disadvantages to this method including high radiation dosage and poor imaging of small 
children' s hearts due to elevated heart rates8 
14 
Figure 3. ALCAPA diagnostic CT. 64 slice CT scan showing the anomalous left 
coronary artery (LCA) originating from the pulmonary trunk (P A) and a dilated right 
coronary artery (RCA) originating from the aorta (Ao). (Zheng et al. , 2011). 
Magnetic Resonance Imaging (MRI) 
The lack of radiation and non-invasiveness of an MRI is a useful diagnostic 
method that can skip the patient the trouble of a cardiac catheter or X-ray coronary 
angiograph/8. It can accurately diagnose ALCAP A without the need of follow-up tests22 . 
MRI can assess the extent ofLV myocardial infarction, wall motion abnormal ities, mitral 
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valve function, and the degree of myocardial steal from LCA to PA22 This information 
can determine the status of the heart preoperatively and aid in the decision of treatment 
method. The downside to this method is the low spatial resolution of images, long exam 
times, and limited visualization of the coronary arteries due to elevated heart rates in 
smaller children4'22 
Table 1. Summary of Diagnostic Differences of ALCAPA Types. Characteristic 
differences that differentiate the type of ALCAP A syndrome in a clinical patient. 
(Modified from A!llistsson et al. , 1962 and Pefi.a et al. , 2009). 
Factor Infant Ty(!e Adult Ty(!e 
Symptoms Colicky pains during or soon after Usually asymptomatic 
feedings, rapid pulse, rapid 
respirations, pallor, and profuse 
perspirations 
Clinical Symptomatic (infarction and Asymptomatic (subclinical 
manifestations heart failure) ischemia and sudden death) 
Auscultation Usually no murmurs, or a Continuous machinery-like 
nonspecific short systolic murmur murmur is often present 
ECG findings Ischemic changes Left ventricular hypertrophy or 
ischemic changes 
Right coronary Mildly dilated Markedly dilated 
arte!]' 
Septal collateral Insufficient Abundant 
vessels 
Wall motion Anterior and lateral wall None or global hypokinesis 
abnormalities hypokinesis 
Left ventricle Dilated Normal or mildly dilated, 
hypetirophy 
Outcome if Myocardial infarction and Sudden death due to ischemic 
unrecognized death in first year of life ventricular dysrhythmias 
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TREATMENT 
Permanent treatment of ALCAP A is surgical, but medication may be needed prior 
to surgery in order to strengthen young infants enough for surgeri5 . Drugs to treat heart 
failure are often used including diuretics, inotropes, and beta-blockers35 . Digoxin is an 
inotropic agent that increases ·the heart ' s ability to pump blood and can also be used to 
. h . 59 60 treat angma, eart pam · . 
Open-heart surgery always carries the risk of complications15 Operative mortality 
rates for ALCAP A treatment have decreased from 75% to 80% in the early 1980s to 0% 
to 23% in the current era24 Table 2 summarizes the surgical treatments of ALCAP A that 
have been used throughout time. 
Surgical Repair of ALCAPA 
One-Coronary Artery Systems 
The first surgical approach developed was a ligation of the anomalous coronary 
artery at its origin from the pulmonary artery29 In this surgery, the aim is to prevent the 
myocardial steal from the LCA to PA39 and improve perfusion ofthe left ventricle6 1 This 
surgery creates a one-coronary artery system with the LCA fi.mctioning as an extension of 
the RCA3 A necessary prerequisite for this surgery is evidence of a well-developed 
communication from the RCA to LCA and a left-to-right shunt from LCA to P A34 
Therefore, in the infantile type, ligation is contraindicated49 Currently, this procedure is 
no longer a recommended mode of treatment for ALCAP A and is only performed as an 
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emergency procedure when extensive LV infarction with ventricular aneurysm has 
already occurred24 
Two-Coronary Artery Systems 
With time, new surgical techniques were established as successful treatments for 
ALCAP A patients of all ages. These methods create a two-coronary-artery system and 
with their low early mortality rates, have become the ideal surgical treatment62 
The aortocoronary bypass technique, first proposed with a saphenous vein graft 
by Cooley and associates in 1966, redirects blood flow from the aorta through a graft and 
into the anomalous coronary artery29 . In the saphenous vein bypass graft procedure, the 
LCA is ligated closed at its origin from the pulmonary trunk and an aortocoronary bypass 
graft is constructed using a segment of the saphenous vein by anastomosing the vein to 
the aorta at one end and to the LCA at the other49 With time, this technique was modified 
using different vessels, such as the subclavian artery or left internal mammary to connect 
the anomalous LCA to the aorta55 The aortocoronary bypass technique minimizes 
intraoperative myocardial ischemia and can be performed without cardiopulmonary 
bypass63 . More recently the left internal mammary anastomosis technique has been 
favored over the left saphenous vein graft as it has shown good results in general 
coronary artery procedures in adults with CAD24. 
Nevertheless, these treatments are not ideal in infants, as the grafts do not enlarge 
as the child grows, and are better suited for more mature patients64 The saphenous vein 
graft procedure is difficult in infants due to the scarcity of vein grafts and small vein 
size24 and is recommended in patients ages 2 years and older49 The subclavian artery 
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aortocoronary bypass technique does manage to revascularize the left coronary artery 
with blood from the aorta, but technical difficulties such as size mismatch between the 
subclavian and coronary arteries and kinking of the subclavian artery have been 
reported55'65 The use of the left internal mammary can be used in older children, but is 
too small in infants as its growth ability has yet to be established55 Currently, these 
techniques are less popular as new and better techniques have developed. 
The common two-coronary artery techniques used today to treat ALCAP A are the 
aortic reimplantation techniques, direct and trap-door, and the Takeuchi procedure. 
The reimplantation technique, also known as direct aortic implantation, is a full 
anatomic correction of ALCAP A 57 . It has become more popular with time due to the 
gained experiences of surgeons from arterial switch procedures used in surgical 
treatments of other CHD36'57 This technique cuts out the anomalous LCA with a cuff of 
the PA wall around it; this "button" is then moved and anastomosed to the aorta66 This 
technique establishes a dual coronary artery system that allows for quick reperfusion of 
the left ventricle and with modification, can be used to treat most ALCAP A 
configurations57 (Figure 3). This technique is suitable for treatment of even the smallest 
infants allowing these patients to be treated promptly after diagnosis64. Yet, this 
technique is more complicated and dangerous to perform in adult patients due to 
increased coronary artery friability, less vessel elasticity, and the potential of tearing and 
bleeding24 . This technique also carries the risk of causing tension if the anomalous LCA 
is far from the aorta, which can lead to long-term complications such as LCA occlusion. 
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Figure 4. Diagrams of ALCAPA direct reimplantation surgical techniques. Each 
picture shows the Aorta with RCA (on left) and PA with anomalous LCA (on right) . Each 
row shows modified techniques for different originations of the LCA from the P A. A) 
Reimplantation of the anomalous LCA originating from the inner aspect of the 
pulmonary trunk wall. B) Reimplantation of the anomalous LCA originating from the 
lateral wall of the pulmonary artery. C) Reimplantation of the anomalous LCA 
originating from the posterior wall ofthe pulmonary artery. (Ramirez et al. , 2011) 
If the anomalous LCA has formed far from the aorta, the trap-door coronary 
transfer technique, also known as the pulmonary artery flap technique, can be used to 
minimize tension62 . The trap-door technique is a modification of the reimplantation 
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technique that aims to lengthen the anomalous LCA pedicle and allow reimplantation to 
the aorta36 This technique first described by Sese and Imoto, cuts a longitudinal 
rectangle-shaped cuff of the pulmonary artery wall surrounding the LCA origin and 
stitches it to a swinging-door shaped flap cut from the amia creating a route for the blood 
from the aorta into the LCA and closing the hole in the aorta67 The trap-door technique 
has proven successful especially in elderly adult type patients as it minimizes anastomotic 
tension and distortion of the LCA 68 This technique can be used in infants and is favored 
over the aortocoronary bypass graft surgeries in children because the viable native tissue 
used has full potential of future growth62'65 This technique offers a very low operative 
risk and flexibility in the placement ofthe LCA63 With modification, this technique can 
be used in any type of ALCAP A69 However, by using the pulmonary artery flap to 
lengthen the coronary artery reimplantation, there is a risk of ischemia during operation 
making it more risky to perform 57 . 
The Takeuchi procedure is used for patients where there is insufficient length of 
the anomalous LCA or when the coronary artery is located originating on a side of the P A 
located far from the aorta 12 This technique uses a flap of vessel wall to create a coronary 
tunnel (baffle) within the pulmonary artery fi-om the origin of the anomalous LCA to the 
aorta through a surgically fashioned communication between the pulmonary artery and 
the aorta, an aortopulmonary window70 (Figure 4). Flow from the aorta is directed into 
the baffle and supplies the LCA70 . The intrapulmonary baffle can be created by using 
tissue from the PA wall, pericardia! tissue, or synthetic material 12 . This surgery is 
indicated for infants and neonates as this surgery uses in situ tissue that maintains its 
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growth potential and can be applied even when the configuration of the LCA is more 
complicated70 . On the other hand, there are recent long-term study findings indicating a 
higher risk of postoperative complications including baffle leakage and pulmonary 
stenosis, a narrowing ofthe pulmonary artery lumen22 
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Figure 5. Diagram of the Takeuchi procedure. A) Dashed lines indicate sites of 
incisions, two adjacent holes are cut out, one in the aorta the other in the pulmonary 
artery, along with a flap of the PA wall creating a window exposing the connection to the 
anomalous LCA. B) A passage created through the adjacent vessel walls of the aorta and 
pulmonary artery by stitching adjacent holes of the vessel walls together. C) & D) The 
flap of the P A is stitched into the inner wall of the P A creating a coronary tunnel inside 
the P A connecting the LCA to the aorta. E) The window in the P A wall is closed and 
surgery completed. (Ginde et al. , 2011) 
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Mitral Valve Repair 
It is still a controversial topic whether the mitral valve should be repaired during 
initial surgery for ALCAP A or not23'57. Some researchers support leaving the mitral valve 
alone in all cases, others believe mitral valve repair should be performed in all patients 
with any form of mitral valve regurgitation (l\1R)23, still others believe that mitral valve 
repair should only occur in the most severe cases57 The difference in opinion is based on 
the variations between patients in regards to mitral valve recoverl4 There are cases of 
pre-operative moderate or even severe valve leakage resolving postoperatively without 
addressing the mitral valve itself52 . In infant type cases with significant l\1R but without 
LV infarction, it is recommended that a repair or replacement of the mitral should not be 
performed, as this regurgitation is most likely secondary to papillary muscle ischemia and 
dysfunction due to ALCAP A and will resolve or diminish after revascularization 
accomplished through ALCAP A repair5 In older children or adolescents with l\1R 
secondary to irreversible myocardial injury or papillary muscle infarction, it is advised by 
some that mitral valve repair should always be performed at the time of the ALCAP A 
. 71 
repa1r surgery . 
In order to effectively repair the mitral valve, it is important that the operation 
should be tailored to the underlying cause ofthe regurgitation23 . A simple annuloplasty is 
commonly used as a treatment for dilation of the mitral valve annulus in which a ring-like 
device is implanted around the valve to tighten the opening, bring the valve cusps closer 
together, and re-establish function23'72 Valve replacements using prosthetic valves are 
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only used in cases of mitral repair failure or unfavorable mitral anatom/7 for example, if 
the valve is thin, flimsy, and beyond repair25 . 
Other Treatments 
Although surgical correction is the only recognized treatment for ALCAP A, in a 
few cases, patients may choose not undergo surgical treatment and use medications 
instead68 . For adult type patients who are symptomatic yet refuse surgery, medical 
treatment such as isosorbide dinitrate and carvedilol can be used to alleviate symptoms 
temporarily, but with time surgery may be ultimately necessarl8 . Isosorbide dinitrate 
dilates the coronary arteries and increases the blood flow to the heart and is used to treat 
for chronic angina pectoris73 Carvedilol, a beta-blocker, relaxes blood vessels and slows 
the heart rate improving blood flow and is used to treat heart failure74 . 
In the infantile type, medical treatment is not enough to alleviate the symptoms of 
congestive heart failure and surgery is the only treatment that can lead to long-term 
survival75 Surgical treatment should be recommended in young patients. In elderly cases 
of adult type ALCAP A, the risk of cardiac surgical treatment outweighs the risk of the 
malformation, and physicians may choose not to intervene surgically47 
As this malformation can lead to end-stage heart failure, there are reported cases 
of heart transplantation as a last resort, but with the advances in medicine today, there is 
less need for such extreme measures even in the presence of substantial myocardial 
changes 24'36 . 
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Table 2. Su mmary of ALCAPA Surgical Techniques 
Treatment Description Pros 
Ligation Closing ofthe anomalous • Can be used to treat patients 
LCA origin from the with adult-type ALCAP A 
pulmonary trunk • Diminishes myocardial steal 
Saphenous vein Aortocoronary bypass using • Two-coronary atiery system 
graft a saphenous vein graft • Used in older patients 
attaching LCA to the aorta • Minimized intraoperative 
ischemia 
Subclavian artery Aortocoronary bypass • Two-coronary atiery system 
anastomosis attaching the subclavian • Used in older patients 
artery to LCA • Minimized intraoperative 
ischemia 
Internal Aortocoronary bypass • Two-coronary artery system 
mammary artery attaching the left internal • Preferred method in adults 
anastomosis mammary artery to LCA • Minimized intraoperative 
ischemia 
Direct aortic The cutting of anomalous • Two-coronary atiery system 
reimplantation LCA from the P A and then • Full anatomical correction 
transplanted onto the aorta • Can be used in infants and 
children 
Trap-door Pulmonary artery flap is • Two-coronary atiety system, 
reimplantation used to lengthen and attach • Grafts will grow with child 
LCA to the aorta • Flexible reimplantation 
• Suitable for all ages 
Takeuchi Creation of baffle inside PA • Two-coronary artery system 
technique directing blood from aorta, • Grafts will grow with child 
through into the LCA • Suitable for all ages 
-
Cons 
• Disastrous if tried in infantile 
type patient 
• One-coronary artery system 
• Difficult to perform in infants 
due to small vessels 
• Size mismatch between graft 
and LCA in infants 
• Kinking of graft 
• Size mismatch between graft 
and LCA in infants 
• Creation of tension if origin of 
LCA is far from the aorta 
• Dangerous in adults 
• Risk of ischemia during 
surgery 
i 
• Technically difficult 
• Grafts must be used to patch up 
hole in pulmonary wall 
PHYSIOLOGICAL OUTCOME 
Evidence suggests that with early diagnosis and treatment, there is the best 
. 1 f LV fu . d 37 76 . d 1 50 I d . potentm o nct10n recovery an outcome ' , even m a u ts . n or er to Improve 
long-term prognosis of patients with ALCAP A, medication for chronic heart failure 
should be continued after surgery until LV size and function are within the normal 
range52 Reduction in hypertrophy and left ventricular dilation after surgery occurs faster 
in infants and children and may be slower or incomplete in adults38 The capacity for 
rapid recovery in myocardial function is due to myocardial hibernation of the tissue36 
Hibernating myocardium is dysfunctional myocardium that has responded to the chronic 
ischemia caused by ALCAP A through myocyte adaptation and down-regulation of heart 
contractility, yet maintains viability and can become fully functional if proper perfusion 
is restored76 Hibernating myocardium will recover postoperatively after reperfusion by 
any technique that establishes a two-coronary artery system24. In general, with a creation 
of a two-coronary system, recovery of LV dilation and function can be expected within 
. 1 69 one year postoperative y . 
After surgery, most patients will be asymptomatic and are classified as New York 
Heart Association (NYHA) class I, although some may be mildly symptomatic and 
categorized as NYHA class II36 NYHA classification is a functional classification of the 
stages of heart failure and helps physicians decide on the best course of therapy by 
relating "patient symptoms to everyday activities and the patient QOL" (quality of 
life)77(Table 3). Quality of life is not the same as health status or physical capabilities of 
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the patient, but about the degree of satisfaction a patient subjectively feels about their 
In a study examining the long-term outcome of pediatric ALCAP A patients, it 
was found that 80% of patients were classified as NYHA class I, 20% were classified 
NYHA class II, and 0% were NYHA class III or IV postoperatively after undergoing a 
. l 69 two-coronary surg1ca treatment . 
Table 3. NYHA Classification. ("Taken from Heart Failure Society of America at 
httrr //www abouthf orgLguestions stages htm" 2012) 
' 
Class Patient Symptoms 
Class I No limitation ofphysical activity. Ordinary physical activity does not 
(Mild) cause undue fatigue, palpitation, or dyspnea (shortness of breath). 
Class II Slight limitation of physical activity. Comfortable at rest, but ordinary 
(Mild) physical activity results in fatigue, palpitation, or dyspnea. 
Class III Marked limitation of physical activity. Comfortable at rest, but less than 
(Moderate) ordinary activity causes fatigue, palpitation, or dyspnea. 
Class IV Unable to carry out any physical activity without discomfort . Symptoms of 
(Severe) cardiac insufficiency at rest. If any physical activity is undertaken, 
discomfort is increased. 
In mix studies ofboth children and adults comparing the Takeuchi procedure and 
reimplantation technique outcomes, there were no significant differences found between 
perioperative, 30-day, and 20-year survival12'36(Figure 6). 
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Figure 6. Postoperative survival after Takeuchi or reimplantation repair. The graph 
postoperative results up to 15 years after surgery in patients who underwent the direct 
reimplantation technique and those who underwent the Takeuchi technique. The graph on 
the left shows post-operative survival throughout the years with a p-value = 0. 77 between 
groups. On the right it shows patient freedom from reoperation throughout the years with 
a p-value = 0.25 . These differences are not large enough to be statistically significant, but 
even in the small sample size ofthis study, the reimplantation technique seems to have a 
slightly better "long-term" result (Ginde eta!. , 2011) 
ALCAP A patients who experienced the trap-door transfer technique have 
comparable outcome to other reimplantation techniques, with most patients achieving 
NYHA class I status and showing systolic function, LV dilation, and MR recovery within 
a year65(Figure 7) . 
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Figure 7. LV improvement after surgical correction of ALCAPA. Graphs show the 
improvement in Left ventricle end-diastolic values (L VEVD) and Left ventricle ejection 
fraction (L VEF) after surgical correction via aortic reimplantation in infants (less than 1 
year old) and older children (older than 1 year old) over time after operation. After about 
3 months, values start reaching the normal range of left ventricular function in both 
infants and children with the infant group showing significant improvement earlier than 
the children group . *p<0.05 when compared with preoperative values. (Alexi-Meskishvili 
et al. , 1994) 
Even with advances in medicine, treated ALCAP A patients must still manage 
their condition as a chronic illness75 Treated patients may consider themselves cured, but 
are at risk of future problems including arrhythmias, heart failure, hypertension, vascular 
complications, and reoperations76 . Myocardium does not heal like other tissues of the 
body and the damage that occurred to the heart preoperatively will always remain to 
some extent. Limitations of myocardial blood flow will persist years postoperativel / 4 
and the possibility of persistent or substructural myocardial damage and subclinical 
ischemia remain and require routine follow-up for monitoring24 For example, in some 
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patients who were treated at an older age, follow-up studies have found patchy fibrosis 
associated with secondary abnormalities in ventricular septal motion76 
Regardless of surgical method, treated ALCAP A patients are at increased risk of 
developing atherosclerosis and coronary artery disease (CAD), even in children58 
Regular exercise helps normal adults and those with acquired CAD reduce symptoms and 
increase quality and/or length of life and may also benefit ALCAP A patients, but the 
issue has yet to be studied82 
Life span estimates for treated ALCAP A patients are unknown as each patient has 
a very unique morphology and most studies have too few patients over 20 years old to 
make a general statement36 . But this problem is also seen in other CHD where life 
expectancy of"normal" to a doctor is based on late outcome studies in patients with CHD 
that on average span a decade and cannot give accurate predictions of entire life span83 . 
Pregnancy and Contraceptives 
There are women with adult type ALCAP A who were untreated, asymptomatic, 
and had multiple uncomplicated pregnancies and deliveries25'38 However, these patients 
are not directly comparable to infant type adult survivors as the cardiac anatomy between 
these groups of patients differs. Asymptomatic adult type pregnant women will not have 
myocardial damage as extensive as that of infant type patients. There is little known 
about infantile type survivors and pregnancy, so a general discussion of mothers with 
treated CHD will ensue. 
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In most cases, mothers with CHD are at low risk during pregnancy and can have 
uncomplicated pregnancies, but since every ACHD patient's cardiac anatomy is different, 
some patients may not be so luckl4 According to Drenthen and colleagues, maternal 
congenital heart defects may put the mother and fetus at risk85 . Even in the average 
mother, pregnancy creates a volume load on the heart that can impact their maternal 
health85. Maternal CHD is associated with a higher chance of infant mortality, premature 
delivery, maternal heart failure, and thromboembolic complications85 . Due to the possible 
genetic etiology of congenital heart defects, there is an increased incidence of CHD 
ranging from 3% to 14% in the infants of mothers with CHD86 Studies show that if a 
mother takes multivitamins, including folic acid, prior to conception she can decrease the 
risk of the CHD in the fetus82. It has been found there is a higher risk of incidence when 
the mother has CHD than if the father has CHD leading to the possibility that inheritance 
may be mitochondrial in some types of CHD82 It is important for ACHD women to 
consult their health care team before pregnancy in order to ensure health for the mother 
and child84 
Even for women with CHD that wish to avoid pregnancy there are still extra risks 
of using hormonal contraceptives. Contraceptive use by women with CHD must also be 
planned carefully due to increased risk of fluid retention or thrombosis with estrogen pill 
use, and risk of endocarditis with intrauterine devices86 
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Surgical Outcome 
Surgical procedures that are beneficial in the short-term may have long-term 
complications that are difficult to predict due to the limited population of patients 
available83 . This next section will be a discussion of the possible complications 
associated with the different surgical techniques (Table 4). 
One-Coronary Artery Systems 
With the ligation surgery, there is evidence of higher early and late mortality 
rates4 1 with reported late mortality rates up to 33%24 By having a one-coronary artery 
system there is increased risk of coronary artery disease6 1 and sudden death with less 
improvement in exercise tolerance75 This surgery does not result in the normalization of 
LV volume or LV ejection fraction after surgery and results in silent myocardial ischemia 
that accounts for the high incidence of sudden death24 It is recommended that patients 
who have survived this surgery undergo reoperation with am1ocoronary bypass grafting 
in order to establish a two-coronary artery system24 
Two-Coronary Artery Systems 
Postoperative mortality after establishment of a two-coronary artery system 
ranges from 0% to 16% and is associated with preoperative risk factors including left 
ventricular dysfunction and severe mitral regurgitation71 . 
In general, aortocoronary bypass procedures have a high incidence of late graft 
occlusion postoperativel/5•70 Saphenous vein bypass surgeries have a reported 80% 
patency in patients with a mean follow-up of5.6 years24 These techniques are especially 
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problematic in infants and small children as grafts have poor growth potential and do not 
enlarge as the child matures63'65 With the left subclavian artery bypass procedure, past 
follow-up studies showed stenosis at the site of anastomosis when used in infants 70 and 
these procedures are no longer used in younger patients. Yet, the thoracic artery graft has 
shown good long-term results when used in older children and adult ALCAP A patients24 
As of 2002, there have been no reports of significant differences between long-term LV 
function or late mortality between aortocoronary bypass procedures and other surgeries 
establishing a two-coronary artery system24 
In a study of pediatric patients who underwent direct aortic reimplantation, 
Azakie and colleagues found that the 1 0-year survival and freedom from reoperation 
from this surgery was about 91% and 93% respectively, with most patients showing 
normalizations of LV ejection fraction and LV dilation, improvement of MR, and 
improvement in wall motion abnormalities within one year71 . Increased tension, as occurs 
when the reimplanted LCA is far from the aorta, is associated with an increased incidence 
of stenosis and obstruction with risk of persistent ventricular ischemia and development 
of postoperative cardiac arrest61. Although rates of coronary occlusion are low, continual 
ventricular dysfunction or mitral regurgitation following a reimplantation technique 
should lead to an evaluation of the patency of the coronary65. If LCA stenosis or 
obstruction occurs, a reoperation aimed at revascularizing the LCA via patch angioplasty 
of the LCA or a coronary bypass graft will be necessarl3 . In cases where the LCA is 
reimplanted between the aorta and the pulmonary artery, there is a risk of anterior 
compression of the LCA by the P A which can lead to poor LV perfusion if the pulmonary 
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trunk is hypertensive63 Cases of late LCA occlusion and stenosis have been reported with 
the trap-door reimplantation technique as well65 
In patients who underwent the Takeuchi technique, late complications include: 
distortion or obstruction of the pulmonary valve, aortic valve insufficiency, baffle 
thrombosis, baffle leak, and supravalvular pulmonary stenosis24'62 By combining the 
results of all Takeuichi case series with a follow-up range between 3. 7 and 15 .9 years, 
Ginde and colleagues found that the most common long-term complications are baffle 
leaks (27%) and moderate or greater supravalvular pulmonary stenosis (24%)12 Baffle 
obstruction (2%) and other complications were not as common12 They also found that 
23% of patients required reoperation to correct surgical complications with the need for 
reoperation increasing over time compared to patients who underwent a direct 
. 1 . 12 1mp antat10n . 
T bl 4 S a e . ummary o fS urgtca 10 utcomes. 
Treatment Prognosis 
Ligation • High risk of atherosclerosis, 
arrhythmias, and sudden death 
• Reoperation advised 
Aortocoronary • High Risk of graft occlusion 
Bypass and stenosis 
• 80% graft patency at ~6 years 
Direct Aortic • Long-term patency 
reimplantation • Good prognosis in most 
Trap-door • Long-term patency 
procedure • Good prognosis in most 
Takeuchi • Long-term patency 
procedure • ~30% chance of complications 
or need of reoperation 
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Possible complications 
• Arrhythmias 
• Recanalization of ALCAP A 
• Severe mitral regurgitation 
• Late graft stenosis and occlusion 
• Grafts may not grow sufficiently 
with infant or child 
• Increased tension of LCA 
• LCA occlusion and stenosis 
• Narrowing ofLCA if reimplanted 
between aorta and P A 
• LCA occlusion and stenosis 
• Supravalvular pulmonary stenosis 
• Aortic valve insufficiency 
• Baffle obstruction 
• Baffle leak 
· Creation ofCoronary-PA fistula 
Mitral Valve 
Mitral valve regurgitation typically improves postoperatively following a two-
coronary system repair with some patients having .MR disappear altogether, and few 
cases that experience no change71 . Mitral valve improvement, if any, occurs more slowly 
than changes in cardiac size and contractility in repaired ALCAP A hearts due to the 
potential irreversible papillary muscle infarction and scarring36 . Not all .MR is relieved 
following ALCAP A repair, and it is advised that if regurgitation persists postoperatively, 
at that time, patients should be assessed for reoperation for repair of the mitral valve52 It 
is estimated that at least one-third of ALCAP A patients who do not undergo initial mitral 
valve repair will present with significant mitral regurgitation years afterwards36,45 
Patients with .MR should continue medication for chronic heart failure after surgery in 
order to improve LV function and delay the need for mitral valve repair45'52 If .MR 
persists, it is most likely due to poor patency of the coronary artery repair and it is 
recommended that a cardiac catheterization be performed to evaluate the need for 
. 23 
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PSYCHOSOCIAL IMPACT 
There is limited data available about the psychosocial impact of growing up with 
ALCAP A, so this section will focus on what patients with similar CHD face, as it can be 
applied to ALCAP A patients. Although there exist CHD that are more or less severe than 
ALCAP A, those will be excluded from this discussion. Based upon primary presentation 
and the need for life-time specialized care these patients, ALCAP A is classified as a 
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severe CHD84 This section will look at the psychosocial status of patients who were 
treated during childhood for severe CHD and their psychosocial experiences growing up. 
The term psychosocial, rather than psychological is used to describe what CHD patients 
face for two reasons: 1) social functioning is more strongly associated with psychological 
functioning than defect severity or other physical factors, 2) the social factors such as 
family, education/career, and friends are the most important aspects of quality oflife87 
In a 25-year follow-up study of grown-up CHD patients, it was found that even 
after treatment, these patients had more psychological symptoms than patients without 
CHD including depression and anxietl7 Although most of these patients will view 
themselves as normal, they may struggle with psychosocial concerns because they are 
never truly cured81. The most common theme expressed by patients living with CHD is 
coping with the presence of the disease and the adjustments patients must make such as 
reduced expectations of life expectancy and social life87 . Most adolescents cope with 
their condition with mixes of emotion from being upset to moving on and not thinking 
about their heart88 Adolescents growing into adults with CHD must establish their 
identity while balancing the independent adult lifestyle with the interdependent life that 
comes with CHD82. 
The emotional health of ACHD patients has yet to be studied82 but many face 
"difficult treatment decisions, surgical preparation, adjustment to implanted cardiac 
devices, heart-focused anxiety, and concerns about mortality" 87 Further surgeries, 
hospital admissions, invasive medical procedures, even follow-up appointments may be 
trigger emotional distress in these patients82 . 
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It is assumed that quality of life (QOL) would depend on ventricular performance, 
yet it has been found that disease severity in CHD is only marginally associated with 
patient quality of life78 . Ability to exercise in CHD patients is a measure of quality of life 
and can measure the long-term effects of the disease after surgery, and patient ability to 
tolerate stress82 With that said, most ALCAP A patients are expected to have a good 
QOL due to little limitations and exercise capabilities. 
Social Life 
It is important for CHD patients to control who, how, and when another person is 
told about their condition88 in order to maintain some kind of privacy. For some patients, 
keeping their CHD a secret from peers can often be difficult when surgical scars or 
physical impairments bring attention to the condition. Many patients feel self-conscious 
about their bodies and scars86 . 
During childhood many individuals with CHD expenence bullying, teasing, 
exclusion by others, and discrimination because of smaller size, lack of stamina, or 
inability to participate in exercising activities leading to feelings of isolation and social 
awk:wardness86'88. These patients are poorly understood by others leading to 
discrimination against them by peers and overprotectiveness by parents, ultimately 
resulting in the inability to be treated like a "normal" child88 With time, peers may begin 
to accept CHD patients as normal individuals, especially in cases with little restrictions or 
physical abnormalities after surgery, and realize that although CHD children are different 
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in some ways, they are just kids like everyone else. Around adolescent age, these CHD 
individuals have reported normal dating86 
Yet, even with time, a fear of discrimination by others persists. A interview study 
found that CHD adolescents are concerned that because of their condition, even if 
corrected, lack of understanding will result in limitations in career choices such as 
exclusion from highly stressful or overtly physical occupations88 There is currently little 
to qualm those fears as there seems to be misunderstanding and stereotyping against 
CHD patients even later in life. There are reported cases of adult CHD patients being 
unable to get loans or having to pay higher premiums because of stereotypes and biases 
of the companies that result in the financial penalization of these patients, without 
d. 1 . 1 . 89 car 10 og1st consu tatwn . 
Around the time that these CHD patients mature into adults and gam 
independence in their lives in areas like education, employment and romantic 
relationships, they must also at this time take on the responsibility of managing their own 
health care87 . With such a great burden of responsibility and discrimination in daily life, 
some patients have found comfort in living dependent lifestyles86 Patients often choose 
to live a more dependent lifestyle due to fear of premature death, economic limitations, or 
the desire for continuous social support82 
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MEDICAL CARE OF ADULTS WITH CONGENITAL HEART DEFECTS 
Due to the advances in medicine over 85% of children born with CHD will 
survive into adulthood, and it is estimated to increase in the next few decades28,84'86 . As 
medical care for ALCAP A has also greatly advanced with time, most of these patients are 
also expected to grow into ACHD adults. Treated adult ALCAP A patients are 
recommended to visit a cardiologist specialist for a regular follow-up every 6 to 24 
months, depending on their current condition84 . Yet, studies have found that many ACHD 
. ·11 c: ·1 . c: ll 81 87 patients w1 1a1 to contmue lO ow-up ' . 
ALCAPA Follow-Up 
Early pediatric ALCAP A patients are some of the first cases surv1vmg to 
adulthood and very little is known about their future health risks. No surgery is perfect, 
and it is important for these patients to seek specialized ACHD medical services regularly 
to ensure good health. For example, those patients who were treated with the Takeuchi 
method should continue follow-up throughout their lives with specialized physicians 
because long-term postoperative complications are common12 
Cardiac catheterization with coronary angiography can be used to assess repair 
patency in patients during follow-up24, but today less invasive methods are preferred. 
Valuable follow-up tests to assess heart flow and function are MRI and CT scans22 . 
Adenosine perfusion MRI studies or an ECG gated multidetector CT angiography can be 
useful postoperatively to determine patency and detect occlusion of the LCA, if anl2'90 
and assess left coronary artery disease90 Even if patients are asymptomatic, these tests 
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could show physicians the current anatomy of the patients and help assess the need for 
future intervention. Cardio MRI is currently used to assess myocardial ischemia in order 
to detect CAD progression in patients and prevent potential irreversible myocardial 
d fu . 58 ys nct10n . 
Some patients with remammg 1\1R are at risk of developing endocarditis83 . 
Patients who have undergone mitral valve repair with prosthetics are at an increased 
risk9 1 Guidelines from the American Heart Association categorize patients by potential 
outcome and recommend prophylaxis treatment, the common preventative antibiotic 
medication for endocarditis, in patients with the worst potential outcomes if infection 
were to occur91. ALCAP A patients should consult with a cardiologist prior to any dental 
or oral procedures in order to prevent risk of infection. 
Little is known about grown-up ALCAP A patients and pregnancy. These patients 
should seek specialist consultation prior to pregnancy in order to ensure maternal and 
fetal health. Yet, currently neither pediatric cardiologist or gynecologist alone can 
provide this advice86 Most ACHD patients are normally at low risk during pregnancy 
and can normally achieve a healthy pregnancy with typical prenatal care, but since 
ALCAP A is more complex, patients should work with a team of physicians including a 
cardiologist, obstetrician, and primary care provider to ensure a healthy pregnancl4 It is 
of crucial importance to monitor the fetal-placental circulation during pregnancy m 
maternal CHD cases in order to maintain health of both the fetus and the mother85 . 
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Growing Up With CHD 
It is important for patients reaching adulthood to establish responsibility over their 
own personal health in order to continue specialized care throughout their lives87 This 
can be difficult when patients change residence, such as when a patient leaves home to go 
to college or when their preferred doctors leave and they must find a new care provider. 
According to Kovacs and Verstappen, to accomplish independence, patients must 
understand 3 key ideas: first, patients must accept their need for life-long specialized 
care, second, patients must be motivated to continue with follow up appointments 
throughout their entire lives, and lastly, patients must know what care they need and how 
. 87 to access 1t . 
As these CHD patients begin emerging as adults (between ages 18-25) there is a 
transition of responsibility of health care management from the parents to the maturing 
CHD patient87 . In order to ease the transfer of pediatric to adult CHD care, it is important 
that all pediatric cardiologists are trained with a basic knowledge of issues that adults 
may face as well as knowing when patients should start seeing a ACHD specialist27 In 
early adolescence, these patients will gradually be encouraged to ask and answer more 
questions during their clinical visits in order to get them used to being involved in the 
process87 It is important for these maturing patients to understand their condition early 
on, so that when they are old enough to manage their own health, they are prepared for 
the responsibility. Yet, if physicians expect too much of the patient too early and supply 
them with unexpected negative information, such as possible future interventions, it can 
be overwhelming to the optimistic adolescents and young adults87 Although some may 
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view this as paternalistic on the part of the physician, these patients need to know what 
they are up against in order to start making their own decisions. A health workbook from 
the American Congenital Heart Association, is aimed at helping patients with how to 
approach the health transition from being dependent on parents to independence, how to 
go from pediatric to adult cardiologist, and what questions patients should ask providers 
to better understand their condition92 . 
Currently, the communication of information between CHD patients and their 
physicians is lacking as it was found that only 50 to 75% of ACHD patients could 
correctly describe their diagnosis when asked82 . This can also be attributed to lack of 
understanding or denial by the patient to accept their condition. If patients have good 
health postoperatively, patients and their families may believe that they are cured and no 
longer need surveillance87 Some patients choose to be noncompliant, such as 
participating in contact sports when their cardiologist has advised them against heavy 
exercise82 . Physicians should make it clear to growing CHD patients that even without 
symptoms, they still need to be monitored routinely by a CHD specialist for the rest of 
their lives87 Because of the chronic condition even after surgery, when compared to adult 
congestive heart failure (CHF) patients, ACHD patients require much longer care than 
most CHF patients do93 . It is believed that a routine follow-up will lead to better patient 
outcomes 82 . However, sometimes loss to follow-up is not the fault of the patient. There is 
a problem in the health care system in working with this group of adults as there are 
reports of patients being unable to get a referral for a cardiologist from their general 
practitioner81 or are told that they no longer need care87 . Yet, when ACHD patients come 
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back for care after years of being lost to follow up, they often return with advanced heart 
failure and other such problems87 
Children and adolescents until around age 18 will receive care from pediatric 
cardiologists, but as the patients age, they will develop adult health risk factors including 
adult cardiac risk factors unrelated to their CHD that the pediatric cardiologist is not 
specifically trained to handle, such as long-term complications, pregnancy, and acquired 
disease27 In addition, pediatric facilities are oriented to children and may not be 
welcoming of new patients above age 18. Adults with ALCAP A may face problems 
when going to a pediatric cardiologist as some clinics may have an upper age limit and 
patients may not be able to go to the children' s hospital for medical care if they are 21 
years or older92 Nevertheless, many adults with CHD choose to continue care with 
pediatric cardiologists due to the difficulty in finding an ACHD specialist28•87 
Although, adult cardiologists are able to deal with acquired cardiac health 
concerns of the aging patients, they are not trained to manage the CHD in patients, 
especially the complex disorders28'94 ACHD patients differ from adults with acquired 
heart disease anatomically and in experiencing growing up with a chronic medical 
condition87 It is important for ACHD patients to understand that the general adult 
cardiologist is not skilled enough to meet their specific needs, as ACHD patients are not 
the "typical" adult heart patient87 . These patients need the same expert surgical care be 
provided to them as children, and as CHD patients mature, they should seek ACHD 
. 1' 84 spec1a 1sts . 
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Table 5. CHD Patient Timeline of Care and Responsibility. 
Age of Patient CHD Health Care Provide•· Health Care l\'Ianager 
0-13 years Pediatric cardiologist Patient's parent(s) 
(child) 
13-18 years Pediatric cardiologist Patient's parent(s) with progressive 
(adolescent) input from patient throughout time 
18-25 years Pediatric cardiologist/ ACHD Patient control without parental 
(young adult) specialist .. supervision 
25 years+ ACHD specialist Patient 
(adult) 
ACHD Medical Services 
The health care needs of the ACHD community are currently unmet93 Yet, these 
patients must find resources available to manage their health the best way possible. Many 
ACHD patients may not be able to find a surgeon well-trained in CHD and may undergo 
operations in centers with low operative volume of ACHD patients, where mortality is 
generally higher for these patients84 Quality of healthcare is dependent on personnel 
training and equipment, the individualization of care, and outcomes93 As of 2001 , the 
workforce caring for ACHD patients was made up of a few adult cardiologists with 
advanced specialized training in CHD and some non-ACHD specialized pediatric and 
adult cardiologists with of on-the-job experience94 For now, if an ACHD specialist 
cannot be found, adults with CHD should seek care of pediatric cardiologists with 
training in adult issues or an adult cardiologist with training in pediatric cardiologi7 
Clinics, such as the Boston Adult Congenital Heart group specialize in care for 
adults with CHD are trying to help meet the need for medical care in this aging CHD 
population95 . Follow-up at an ACHD center offers better timing and methods of 
intervention, follow-up strategies, and general medical advice to this unique group of 
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patients84 In order to overcome the shortcoming between specialists and provide the best 
comprehensive ACHD care, some clinics provide joint adult and pediatric cardiologists 
for the care of patients94 These regional ACHD centers can also work with family 
doctors that provide local care in order to ensure well-rounded patient care93 . The 
American Congenital Heart Association offers a ACHD program directory that can help 
direct patients to the specialized care they need87 However, the number of ACHD clinics 
in the United States is currently too few95 
The best case scenario for ACHD medical care would be if more 
medical/pediatric care providers board-certified in both adult and pediatric cardiology 
that would provide these patients with the specialized care they need27 Programs for 
adult cardiology training in CHD are being created in the United States in order to create 
ACHD subspecialist cardiologists that will be able to provide specialized care for the 
growing ACHD population94 Patients may require interventional therapy or reoperations 
as adults which would require a new set of skills from physicians to meet future needs of 
h . 93 t ese patients . 
Even if a patient does find a specialist, there are still challenges facing the ACHD 
field as there are so few patients in each category of CHD. It is difficult to establish a 
protocol for how to treat patients93 while also avoiding making assumptions about this 
group as they are all very unique87 
45 
Access to Care 
Being born with a congenital heart defect can be costly with all of the doctor' s 
appointment and tests needed throughout life. Many young American adults ages 19-21 
fail to get medical care because it is too expensive96 and with an underlying medical 
condition, such as ALCAP A or a complex CHD, it can be even more costly. "Access to 
optimal, specialized, appropriate health care, health and life insurance, and full 
employment remains a problem for many adolescent and adult patients with congenital 
heart disease (CHD)"97 Once into adulthood these patients are no longer covered by 
parents insurance and getting health insurance can be expensive and difficult compared to 
the average American of the same age86'97 . For decades, patients with pre-existing 
medical conditions have been charged more for the health insurance premiums they need 
in order to afford the lifetime of medical care they need. 
With recent the passing of the Mfordable Care Act, there are some benefits that 
will affect the ACHD community. Currently, children under age 19 can no longer be 
limited or denied benefits by health insurance companies due to a pre-existing condition, 
and starting in 2014, this law will also protect Americans of all ages regardless of pre-
existing condition or gender98. Until 2014, this act also has a bridging program, called the 
Pre-Existing Condition Insurance Plan, for US citizens and legal residents over age 19 
who have been denied health insurance due to a pre-existing condition and have been 
uninsured for at least 6 months98 This law also extends the age which young adults can 
be covered by their parent's plan from 19 to 2696'98 . Beginning in 2014, those who can 
no longer join their parent's insurance plan will have new affordable insurance options96 . 
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When this law comes into full effect, the specialized medical care that ACHD patients 
require should be more economically accessible. 
FINAL COMMENTS 
Since its discovery in the early 1900s, there have been great medical advances in 
the understanding and treating of ALCAP A that have allowed many patients to survive 
into adolescence and adulthood. What was once a death sentence can today be minimized 
to a mild heart condition. Yet, it cannot be denied that this malformation is life altering. 
Starting from multiple diagnostic tests in childhood, to surgical treatment, recovery, and 
life-long follow-up, ALCAP A is a tolling experience financially and emotionally. Even if 
patients are asymptomatic years post-operatively, they are at risk for developing early 
CAD, endocarditis, further mitral valve regurgitation, and surgical complications. 
After surgical recovery, this group of patients should have no problem exercising 
and in most daily activities. It seems that most ALCAP A patients should be able to live 
"normal" productive adult lives, but because of the CHD, there are extra obstacles and 
responsibilities that these patients must prepare for such as obtaining health insurance, 
discrimination, and learning to manage their own unique health. When it comes to 
pregnancy, contraceptives, and other medical or dental procedures, these patients must 
always consult with their health care team, including a specialized ACHD cardiologist, in 
order to ensure the best outcome. Nevertheless, even with all of the advances made thus 
far, there is still much more to be known about ALCAP A 
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First, it should be investigated whether infant screening before symptoms develop 
and prompt treatment after diagnosis would prevent myocardial damage and improve 
outcomes. This should be done by ultrasound, attempting to view the coronary arteries, as 
well as the rest ofthe cardiac anatomy. Yet, because ofthe unlikelihood of ALCAPA in a 
given infant, the benefit of detecting ALCAP A early may not outweigh the cost of 
screening every infant. Maybe with new advances in screening technology something 
more practical can make this study feasible and potentially eliminate severe ALCAP A 
presentations. 
Secondly, outcome studies of ALCAP A survivors m general are lacking. 
Although most ALCAP A survivors can exercise, it is unknown if exercise can be 
beneficial in reducing patient's risk of CAD and lead to better long-term outcomes. In 
addition, there is little information for grown-up ALCAP A survivors in respect to 
pregnancy and life expectancy estimates. Because of the limited number of ALCAP A 
patients, loss of follow-up, and individual physiology of each patient, this information 
will not be known for years to come. With the current surgical techniques, there have 
been few to no "long-term" postoperative deaths reported with the Takeuchi, direct aortic 
reimplantation, or trap-door techniques with data spanning up to 20 years 
postoperatively. But, since most treated ALCAP A patients have altered cardiac function 
to some extent, it will be interesting to see what happens to these patients 30, 40, or even 
50 years postoperatively. 
Thirdly, the specialized medical care for the ACHD patient population is flawed . 
Patients discontinue follow-up when they feel "better," poor understating of their 
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condition, cost limitations, or when the time comes to change from a pediatric 
cardiologist to an ACHD provider. Physicians need to stress the importance of follow-up 
care to patients in order to prepare them for a lifetime of specialist care. When it comes to 
the young adult transition of cardiac care, there are no set guidelines to follow, but it may 
be helpful if physicians play a bigger role in guiding these patients in the right direction. 
Since the ACHD field is somewhat a new creation, it will take time until it becomes fully 
capable of meeting patient needs. It is important that future ACHD providers understand 
the whole patient in order to help these patients thrive. 
There are still many things unknown about ALCAP A, but with the efforts of 
pediatric cardiologist and ACHD health centers, even patients with the most severe 
presentations can be treated surgically and may survive into an asymptomatic adulthood. 
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